Reed B. Hogan, M.D., Gastroenterologist

Reed B. Hogan, M.D., began his medical training at Delta State University where he received his Bachelor of Science in Biochemistry. He then attended the University of Mississippi School of Medicine where he received his M.D. in 1980. He fulfilled his residency and internship requirements in Internal Medicine at the University of Mississippi Medical Center and completed a fellowship in Gastroenterology at Baylor University Medical Center in 1985. Following the fellowship he came to work for G.I. Associates. He is board certified in Internal Medicine and Gastroenterology. Dr. Hogan is both an accomplished speaker and writer in the field of Gastroenterology.

I am accepting new patients.

Gastroenterology

Internal Medicine

MD - University of Mississippi School of Medicine : 1980
Internship/Internal Medicine - University of Mississippi School of Medicine : 1983

Residency/Internal Medicine - University of Mississippi Medical Center : 1983

Fellowship/Gastroenterology - Baylor University Medical Center : 1985

Clinical Assistant Professor of Medicine : 1986
University of Mississippi School of Medicine
Jackson, MS
1986 - Present

Research Studies : 2006

1. A phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of the three different doses of XXXXX administered bid for either two or four weeks in the treatment of patients with diarrhea-associated irritable bowel syndrome.

Research Studies : 2005

1. A phase 2, randomized, open-label study to assess the safety and efficacy of xxxx versus xxxx for sedation in elderly patients undergoing colonoscopy procedures.

 

Research Studies : 2004

1. A phase 3 multi-center, randomized, double-blind, placebo-controlled, parallel-arm study of the efficacy and safety of xxxx in the treatment of subjects with active ulcerative colitis.
2. A double-blind, placebo-controlled study of xxxx maintenance intermittent A phase 3, multi-center, 52 week, open-label, extension study of the safety and efficacy of xxxx in the treatment of patients with ulcerative colitis.
3. A multi-center, randomized, double-blind, placebo-controlled study of the efficacy and safety of XXXX XXX in patients suffering from functional dyspepsia.
4. A randomized, double-blind, dose-response study to assess the efficacy and safety of XXXXX injection for procedural sedation in patients undergoing colonoscopy.
5. Determination of the Minimal Clinically Important Difference (MCID) of the patient-orientated self assessment scale Request in patients suffering from endoscopically confirmed Gastroesophageal Reflux Disease (GERD), Grade A-D according to Los Angeles classification treated with XXXXXX or placebo over one week.
6. A phase 3 Study to Evaluate the Efficacy and Safety of XXXXX compared to Placebo on Symptom Relief in Subjects with Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD).
7. A phase 3, Open-Label Study to Assess the Long-Term Safety of XXXXX.
8. A phase 3 Study to Evaluate the Efficacy and Safety of XXXXX and an Active Comparator, XXXXX on healing of Erosive Esophagitis.
9. A phase 3 Study to Evaluate the Safety and Efficacy of XXXX compared to placebo in maintenance of healing in subjects with healed Erosive Esophagitis.
10. Efficacy and Safety of xxxxx for treating heartburn in frequent sufferers.
11. A phase 3, randomized, double-blind, dose-controlled study to assess the efficacy and safety of XXXXXX injection for minimal-to-moderate sedation in patients undergoing colonoscopy therapy following acute treatment in patients with symptomatic gastroesophageal reflux disease.
12. A multi-center, open-label, study of the xxxx to evaluate the long term safety and tolerability of repeated administration of xxxx in subjects with crohn’s disease.
13. A multi-center, randomized, double-blind, placebo-controlled study of the xxxx for the induction of clinical remission in subjects with moderate to severe crohn’s disease who have lost response or are intolerant to xxxx.
14. A multi-center, randomized, double-blind, placebo-controlled study of the efficacy and safety of xxxx in patients suffering from functional dyspepsia.

Research Studies : 2003

1. Multi-Center, Double-Blind, Randomized, Placebo-Controlled Phase III Study of the Efficacy and Safety of Oral XXXX for the Treatment of Occasional Constipation
   Double-Blind, Placebo-Controlled, Randomized, Multi-center Study to Investigate the Safety and Efficacy of 2 mg TID of XXXX over 12 weeks in Diarrhea-Predominant Irritable Bowel Syndrome Subjects
2. Functional Dyspepsia
3. Multi-center, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates for Once Daily Treatment with XXXX 20 mg and XXXX 15 mg for 6 months in Patients whose Erosive Esophagitis has been healed
4. Comparative Efficacy and Safety Study of XXXX Delayed-Release Capsules 40 mg qd and 20 mg qd versus XXXX150 mg bid for the Healing of NSAID- associated Gastric Ulcers when Daily NSAID use is continued
5. Comparative Efficacy and Safety Study of XXXX Delayed-Release Capsules 40 mg qd and 20 mg qd Versus Placebo for the Prevention of Gastric and Duodenal Ulcers Associated with Daily NSAID Use in Patients at Risk  
6. Randomized, Double-Blind Trial Comparing the Early Profile of Heartburn Relief Associated with XXXX 20 mg daily Versus XXXX 20 mg once daily in Gastroesophageal Reflux Disease Patients with an Acute or Documented History of Erosive Esophagitis
7. Randomized, double-blind, placebo-controlled, dose finding, multi-center study to assess the efficacy, safety and tolerability of XXXX given orally at three doses 1.5 mg, 6 mg or 18 mg and placebo in patients with functional dyspepsia and documented normal gastric emptying
8. 10 day pre-screen XXXX plus aspirin versus XXXX plus aspirin versus placebo versus aspirin; two UGI endoscopies in 7 days, healthy adults 50-75

 

Hospital Affiliations

King’s Daughters Hospital

Brookhaven, MS

1997 – Present

 

Hardy-Wilson Memorial Hospital

Hazlehurst, MS

1997 – Present

 

Crossgates River Oaks

Brandon, MS

1995 – Present                                                                              

 

Regency Hospital

Jackson, MS

2006 - Present

 

St. Dominic/Jackson Memorial Hospital

Jackson, MS

1985 – Present

 

Mississippi Baptist Medical Center

Jackson, MS

1985 – Present

 

River Oaks Hospital

Jackson, MS

1985 – Present

                                   

Woman’s Hospital at River Oaks

Jackson, MS

1985 – Present

Post Graduate and Continuing Education Courses

1. Digestive Disease Week 2009, Chicago, IL May 30 – June 4, 2009
2. Endoscopic Sedation Issues in 2009, Chicago, IL June 2, 2009 CME credits 1.25
3. Applying New Evidence to Clinical Practice, Chicago, IL May 30 – 31, 2009 CME credits 15.0
4. Gastrointestinal Endoscopy Manuscript Review: Oval Cup Forceps, versus Serrated Jaw Forceps in Gastric Biopsy, June 2008. CME credits 3.0
5. Gastroenterology Practice and Endoscopic ASC’s 2008, Challenges and Opportunities, Knoxville, TN April 10 – 13, 2008
6. Endoscopy Unit Management in the 21st Century: Issues, Solutions, and Plans for the Future, Washington, DC, March 29 – 30, 2008
7. Mississippi Gastroenterology Society Annual Meeting, Jackson, MS February 9, 2008 CME credits 5.0
8. Digestive Diseases Week 2007, Washington, DC, May 19-24, 2007, CME credits 19
9. Solutions for Successful Practice Management, Seattle, Washington 8/16 – 8/19/07
10. UpToDate CME credits 216.5, 7/06 – 4/07
11. MS Gastroenterology Annual CME  (5 hours) 2/11/2006
12. UpToDate CME credits 49.75, 7/04 – 8/05
13. Clinical Advances in Gastroenterology. (4 hours) 7/03
14. Practical Reviews in Gastroenterology.  CME credits Ethics. (2 hours) 7/03
15. Practical Reviews in Gastroenterology. (39 hours) 12/02 – 11/03
16. The University of Chicago and The Crohn’s and Colitis Foundation of America.  Practical Issues in the Maintenance, Monitoring and Surveillance of Inflammatory Bowel Disease. 3 CME hours, 01/14/98.
17. Albert Einstein College of Medicine.  Practical Review in Gastroenterology.  42 hours. 12/96 – 11/97.
18. American College of Gastroenterology.  Clinical Advances in Gastroenterology.  4 CME hours 12/96 – 11/97.
19. Affiliated Research Center, Fall Research Conference, Chicago, IL. 09/26 – 09/28/97.
20. Projects in Knowledge.  Chronic Hepatitis C: Optimizing Patient Management in 1997.  1 CME hour.  08/25/97
21. Baylor College of Medicine.  Managing Peptic Ulcer Disease in the Era of Helicobacter Pylori.  2 CME hours.  07/22/97.
22. Audio Digest Foundation.  Specialty – Gastroenterology.  6 CME hours.  05/97.
23. Abbott Gastroparesis – Primary Investigator, Palm Beach, FL.   04/97
24. Baylor College of Medicine.  Helicobacter Today.  1 CME hour. 03/24/97.
25. Affiliated Research Center, Spring Research Conference, Chicago, IL.  03/14/ - 03/16/97.
26. Affiliated Research Center, Good Clinical Practices, Fall Research Conference, Dallas, TX.  01/17/97.
27. Affiliated Research Center, Fall Research Conference, Dallas, TX. 10/13/96.
28. Temple University School of Medicine.  Hospital Medical CME Credit (9 hours). 05/95 – 09/95.
29. Medical Assurance Company of Mississippi.  Hospital Risk Management Seminar. 1995.
30. Albert Einstein College of Medicine.  Gastroenterologists Clinical Update. (3 hours) 12/94 – 11/95.
31. Practical Reviews in Gastroenterology. (21 hours) 12/94 – 11/95.
32. Challenges in Gastroenterology: Helicobacter Pylori and Gastrointestinal Disease, Medical College of Georgia. (1 hour) 09/01/94 – 03/31/95.
33. California Medical Association.  Gastroenterology (8 hours). Temple University of Medicine.  01/94 – 01/95.
34. Hospital Medicine CME (12 hours).  01/95
35. Tufts University of Medicine.  CME Infectious Disease (4 hours). 01/94 – 01/95.
36. Temple University School of Medicine.  Hospital Medicine, Jan/Feb. (18 hours) 01/94 -  01/95.
37. Albert Einstein College of Medicine.  Gastroenterologist’s Clinical Update (12 hours). 12/93 – 11/94.
38. Clinical Advances in Gastroenterology.  American College of Gastroenterology (6 hours). 12/93 – 11/94.
39. Practical Reviews in Gastroenterology.  Albert Einstein College of Medicine (24 hours).  12/93 – 11/94.
40. Temple University School of Medicine.  Hospital Medicine.  (12 hours). 01/93 – 12/93.
41. Albert Einstein College of Medicine.  Gastroenterologist’s Clinical Update (6 hours). 12/92 – 11/93.
42. American College Gastroenterology Clinic.  Advance in Gastroenterology. (2 hours). 12/92 – 11/93,
43. Practical Reviews in Gastroenterology: Albert Einstein College of Medicine (33 hours). 12/92 – 12/93
44. Tufts University School of Medicine.  Infections in Medicine.  (3 hours). 12/29/93.
45. Temple University School of Medicine.  Hospital Medicine (3 hours). 11/01/93.
46. ASGE Post-Graduate Course: Boston Endoscopy and GI Cancer. (12 hours) 05/20/93.
47. Temple University School of Medicine.  Hospital Medicine CME Credit (3 hours).  03/01/93.
48. Albert Einstein College of Medicine.  Practical Reviews in Gastroenterology (12 hours).  12/09/92.
49. Albert Einstein College of Medicine.  Gastroenterologist’s Clinical Update (4 hours).  12/09/92.
50. Audio Digest – California Medical Society of Gastroenterology.  (10 hours). 01/92 – 12/92.
51. Temple University School of Medicine.  Hospital Medicine CME Credit (9 hours). 10/01/92.
52. Update on Colon Cancer.  St. Dominic (1 hour). 09/01/92.
53. Update in Gastroenterology.  Montreal, Canada.  08/24/ - 08/27/89.
54. American Society Gastrointestinal Endoscopy Post-Graduate Course, Washington, DC. 05/18/89 – 05/19/89.
55. Digestive Disease Week, Scientific Session.  Washington, DC.  05/13 – 05/17/89.
56. Non-Steroidal Induced Gastric-Mucosal Injury: New Concepts in Therapy, Dallas, TX. 03/17 – 03/19/ 89.
57. Evolving Concepts in GI/Hepatic Diseases.  Orlando, FL. 02/10 – 02/12/89.
58. Perspectives on Upper GI Disease Management, Focus on H2-Receptor Antagonist Therapy.  Scottsdale, AZ.  01/89 – 12/89.
59. AGA Digestive Disease Week, Scientific Session. New Orleans, LA.  05/15 – 05/18/88.
60. Therapeutic ERCP & ERCP Manometry of the Sphincter of Odd: St. Luke’s Hospital, Racine, WI.  10/08 – 10/10/87.
61. AGA Digestive Disease Week, Scientific Session, Chicago, IL.  05/11 – 05/13/87.
62. Society of Surgery of the Alimentary Tract Post-Graduate Course. “Inflammatory Bowel Disease”.  Chicago, IL.  05/10/87.
63. Garren-Edwards Gastric Bubble Training Symposium.  01/01/86.
64. AGA Digestive Week, Scientific Session, San Francisco, CA.  05/18 – 05/22/86.
65. AGA Post-Graduate Course, San Francisco, CA. 05/17 – 05/18/86.
66. American Society for Gastrointestinal Endoscopy, New York.  Timely Topics and Challenges in Gastroenterology and Endoscopy.  05/16 – 05/17/85.
67. AGA Digestive Disease Week, Scientific Session, New York. 05/12 – 05/16/85.
68. AGA Post-Graduate Course, New York, Current Concepts in Physiology and Pathophysiology of the Exocrine Pancreas.  05/11 – 05/12/85.
69. American College of Physicians – Texas Regional Meeting.  12 credit hours in category one.  11/84.
70. The American College of Gastrointestinal Endoscopy.  New Orleans, LA.  Controversies in Gastrointestinal Endoscopy. 05/24 – 05/25/84
71. American Gastroenterology Association.  Digestive Disease Week.  New Orleans, LA.  Annual scientific Session.  05/20 – 05/23/84.
72. American Gastroenterology Association.  Post-Graduate Course – Inflammatory Bowel Disease. 05/19 – 05/20/84.
73. 5th Annual International Gastroenterology Conference, Orlando Regional Medical Center, Orlando, FL.  02/23 – 02/25/84.
74. The 64th Annual session of the American College of Physicians.  San Francisco, CA.  04/11 – 04/14/83.

 

Gastroenterology/Internal Medicine

Practice Management Committee Appointee : 2008
American College of Physicians - Member
American Society of Gastrointestinal Endoscopy
American Gastroenterology Association
Mississippi State Medical Association
American Medical Association
Alpha Omega Alpha
Central Medical Society
Jackson Academy of Medicine

Elected by his peers for inclusion in Best Doctors in America® : 1996-2006

Two Year Retention of Bravo Capsule in a Giant Colonic Diverticulum : 2009

Hogan, II, RB, Phillips, MP, Boyd, SA, Williams, JC, Hogan, III, RB.
American Journal of Gastroenterology, 2009; 104:1062; doi: 10.1038/ajg. 2008. 176

Video Capsule Endoscopy in Life-Threatening Gastrointestinal Hemorrhage Following Negative Primary Endoscopy. : 2008

Hogan, II, RB, Hogan, III, RB, Phillips, MP Pareek, N.
Gastrointestinal Endoscopy, 2008.  

Epinephrine Preinjection of Stalked Colonic Polyps. : 2008

Hogan, II, RB, Hogan, III, RB. Epinephrine Preinjection of Stalked Colonic Polyps.  Gastrointestinal Endoscopy, 2008, 67, 1214.  Letter to the editor response.

Epinephrine Preinjection of Stalked Colonic Polyps. : 2008
Hogan, II, RB, Hogan, III, RB.

Gastrointestinal Endoscopy, 2008, 67, 1214.  Letter to the editor response.

Cost-minimization Analysis of Jumbo Reusable Forceps Versus Disposable Forceps in a High-Volume Ambulatory Endoscopy Center. : 2008

Hogan, II, RB, Santa-Cruz, R, Weeks, ES, Sears, LK, Hogan, III, RB. 
Gastrointestinal Endoscopy, 2008, 69, 284-288.

Crystal-Storing Histiocytosis Due to Massive Accumulation of Charcot-Leyden Crystals : 2007

 A Unique Association Producing Colonic Polyposis in a 78-year-old Woman With Eosinophilic Colitis.
Lewis, J, Candelora, J, Hogan, II, RB, Briggs, F, Abraham, S. 
Am J Surg Pathol.  2007 Mar;321 (3):481-485

 

Video Capsule Endoscopy Detection of Jejunal Carcinoid in Life Threatening Hemorrhage, First Trimester Pregnancy. : 2007

 Hogan, RB, II, Ahmad, N, Hogan, III, RB, Hensley, SD, Philliips, MP, Doolittle, Reimund, E.
Gastrointestinal Endoscopy, 2007, 66, 205-207.

Epinenephrine Volume Reduction of Giant Polyps Facilitates Endoscopic Assessment and Removal. : 2007

Hogan, II, RB, Hogan, III, RB. 
Gastrointestinal Endoscopy, 2007, 66; 1018-22.

Using A Sponsorship to Improve the Success of Blood Drive Donations. : 2007

Hogan, MB, Hershey, L, Hogan, II, RB, Callum, C.
Health Care Marketing Quarterly 2007, 24, 51-61.

Malfunctioning Percutaneous Endoscopic Gastrostomy Tube Exchange/Replacement. : 1997

Hogan, II, RB, et al.
Gastrointestinal Endoscopy, 1997 

Hydrostatic Balloon Dilators—Changing the Approach to Gastrointestinal Strictures. : 1986

Hogan, II, RB, Polter, DE, Hamilton, JK. 
Gastrointestinal Endoscopy, 1986; 31:154 Abstract.

Hydrostatic Balloon Dilators Fair or Foul. : 1986

Hogan, II, RB, Polter, DE, Hamilton, JR, Walter CO. 
Journal of Gastroenterology, 1986: vol 8, No. 4:494.

Percutaneous Endoscopic Gastrostomy – To Push or Pull: A Prospective Randomized Trial. : 1986

Hogan, II, RB, Demarco, DC, Hamilton, JK, Walker, CO, Polter, DE.
Gastrointestinal Endoscopy, 1986; vol 32, No. 4:253-258.

Preliminary Experience with Hydrostatic Balloon Dilation of Gastric Outlet Obstruction. : 1986

Hogan, II, RB, Hamilton, JK, Polter, DE. 
Gastrointestinal Endoscopy 1986; vol 32, No. 2:71-74.

Nonsurgical management of Lye-Inducted Antral Stricture with Hydrostatic Balloon Dilation. : 1986

Hogan, II, RB, Hamilton, JK, Polter, DE. 
Gastrointestinal Endoscopy 1986; vol 32, No. 3:228-230.

Common Bile Duct Evaluation in the Era of Laproscopic Cholecystectomy 1050 Cases Later.

Voyles, CR, Sanders, DL, Hogan, II, RB. 
Annals of Surgery, vol 219, No.6, 744-756.

The Gastric Bubble-vs-Sham Endoscopy: A Prospective Randomized, Controlled, Double-Blinded Comparison as an Adjunct to a Standard Weight Loss Program

Hogan, II, RB, Johnston, JH, Long, BW, Sones, JQ, et al. 
(Abstract) Gastrointestinal Endoscopy, 1987; 33:172.

Pseudohyperparathyroidism complicated by Primary Hyperthyroidism.
Hogan, Gasparis, Nelson and Jackson.  Submitted for publication.
Studies of The Prevalence and Significance Of Radiolabeled Rice Acid Malabsorption in A Group of Patients With Idiopathic Chronic Diarrhea.
Schiller, LR, Hogan RB, Morawski, SG, Santa Ana, CA, Bern MJ, Nogaard, RP, Bo-Linn, GW, Fordtran JS.